UNSPSC 51434909: Amlodipine/olmesartan

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434909 Amlodipine/olmesartan is a Commodity code that represents pharmaceutical products, though recent state and local procurement activity under this code shows little direct relevance to the code's nominal scope. The City of Tampa's Purchasing Department issued an IFB in April 2026 for Advanced Life Support Medications to supply Tampa Fire Rescue, but the solicitation specified four distinct medication line items—Labetalol HCI, Epinephrine, Adenosine, and Diltiazem—rather than the amlodipine/olmesartan combination the code nominally describes. State and local governments procure medications through this taxonomy for emergency medical services, fire departments, and healthcare delivery, typically in unit quantities tied to operational demand and subject to strict expiration-date requirements, warranty provisions, and OSHA compliance documentation.

The City of Tampa's April 2026 solicitation (26P00188, due April 8, 2026, estimated value $40,000.00) represents the identifiable recent activity under this code. Vendors were required to supply medications with nine-month minimum shelf life from acceptance, arrange pickup and replacement of expired stock, and deliver within ten calendar days of order receipt. The contract carried a one-year term with two optional one-year renewals and up to three unilateral 30-day extensions, and included a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount capped at $10,000. Bidders had to submit Safety Data Sheets compliant with OSHA Hazard Communication Standards and accessibility documentation conforming to WCAG 2.2 Level AA and Section 508 standards. The mismatch between the code's stated product (amlodipine/olmesartan, a hypertension medication combination) and the medications actually solicited (emergency cardiac and resuscitation drugs) suggests limited current alignment between this Commodity code's scope and active state and local procurement activity.